ONCO - Onconetix, Inc.
0.6664
-0.061 -9.199%
Share volume: 1,143,088
Last Updated: 04-23-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.73
-0.06
-0.08%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 06-12-2025 | 11-13-2025 | 03-13-2026 | |
| Total revenue | 101.630 K | 303.651 K | 303.596 K | |
| Cost of revenue | 55.798 K | 34.757 K | 55.912 K | |
| Gross profit | 45.832 K | 268.894 K | 247.684 K | |
| 486.69% | -7.89% | |||
| Operating expenses | 1.699 M | 2.338 M | 1.529 M | |
| Selling general and admin | 1.674 M | 2.341 M | 1.505 M | |
| Research and development | 24.455 K | -3.211 K | 24.293 K | |
| Total expenses | 12.617 M | 2.338 M | 1.529 M | |
| -81.47% | -34.60% | |||
| Operating income | -12.571 M | -2.069 M | -1.281 M | |
| Ebit | -8.322 M | -3.099 M | 5.674 M | |
| Pretax income | -8.546 M | -8.784 M | 5.670 M | |
| 2.78% | -164.55% | |||
| Income tax | 0.000 | 0.000 | 525.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -8.546 M | -8.784 M | 5.670 M | |
| -2.78% | 164.55% |